AIP Form 144: Multiple 10b5-1 Sales Recorded
The filing reports proposed and completed dispositions of Common stock by affiliated holders using 10b5-1 plans and private acquisitions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The filing reports proposed and completed dispositions of Common stock by affiliated holders using 10b5-1 plans and private acquisitions. The excerpt lists multiple 10b5-1 sales by BAYVIEW LEGACY, LLC and one by K. CHARLES JANAC between 03/09/2026 and 05/08/2026, with individual sale quantities and dollar amounts recorded.
The filing also lists earlier private acquisitions from the issuer on 11/05/2013 (50,000 shares) and 02/05/2016 (20,000 shares). Transaction timing and per-sale proceeds are shown next to each sale date.
Insights
Multiple scheduled dispositions under 10b5-1 plans are disclosed by affiliated holders.
The excerpt lists a sequence of 10b5-1 sales by BAYVIEW LEGACY, LLC on 03/09/2026, 03/10/2026, 03/25/2026, 03/26/2026, 04/08/2026, and 05/08/2026, plus a 10b5-1 sale by K. CHARLES JANAC on 04/06/2026. Each row pairs share counts with proceeds in dollars, indicating executed plan trades.
These entries reflect scheduled dispositions rather than company capital actions; cash‑flow recipients are the selling holders. Subsequent filings may provide additional transactional context such as total holdings after sales.
Sales are recorded under Rule 10b5-1 mechanics and include per-trade proceeds.
The excerpt shows per-trade data (shares and dollar proceeds) — for example, 70,000 shares for $2,183,986.00 on 05/08/2026 and multiple earlier trades. The filing also documents prior private acquisitions dated 11/05/2013 and 02/05/2016.
Compliance reviewers will verify that each sale aligns with the disclosed 10b5-1 plan terms and applicable holding-period rules; the excerpt itself does not state plan start dates or remaining holdings.
Key Figures
Key Terms
10b5-1 regulatory
Private Acquisition from Issuer or an Affiliate market
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What 10b5-1 sales does AIP's Form 144 list?
Who are the sellers named in this AIP Form 144 excerpt?
Are per‑trade proceeds disclosed in the excerpt?
Does the excerpt state who receives sale proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.